Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 4:07 AM
Ignite Modification Date: 2025-12-26 @ 3:03 AM
NCT ID: NCT02462720
Description: None
Frequency Threshold: 5
Time Frame: A period of time ending at Week 4 (day 32)
Study: NCT02462720
Study Brief: COMFORT: A Multicenter, Open-label, Randomized, Crossover Study
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Varithena® Varithena® treatment in accordance with full prescribing information and instructions for use Radiofrequency ablation: Radiofrequency ablation conducted per physicians' standard of care. 0 None 0 34 4 34 View
Radiofrequency Ablation Varithena® treatment in accordance with full prescribing information and instructions for use Radiofrequency ablation: Radiofrequency ablation conducted per physicians' standard of care. 0 None 0 34 3 34 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Pain in extremity SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders None View
Phlebitis SYSTEMATIC_ASSESSMENT Vascular disorders None View